Lonza Group (LZAGY) Expected to Release Earnings on Wednesday

Lonza Group (OTCMKTS:LZAGY) is anticipated to release its resultson Wednesday, July 22nd. Analysts expect Lonza Group to announce earnings of $1.09 per share and revenue of $4.2394 billion for the quarter.

Lonza Group Price Performance

Shares of OTCMKTS:LZAGY opened at $71.59 on Wednesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.24. Lonza Group has a 52-week low of $58.53 and a 52-week high of $73.85. The stock’s fifty day simple moving average is $64.38 and its 200-day simple moving average is $65.53.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Lonza Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 8th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Lonza Group has a consensus rating of “Moderate Buy”.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.